Treatment of Hyperlipedemia with Unani formulatio
Phase 2
Completed
- Conditions
- Health Condition 1: I259- Chronic ischemic heart disease, unspecifiedHealth Condition 2: null- Hyperlipidemia
- Registration Number
- CTRI/2018/05/013864
- Lead Sponsor
- Central Council for Research in Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1.Serum cholesterol: > 200 mg/dl
2.Serum Triglycerides: >150 mg / dl
3.LDL: > 115 mg/ dl
4.HDL: > 40
5.Patient should be willing to cooperate the study protocol
6.Patient should be give written informed consent
7.Patient should not have any other disease.
Exclusion Criteria
1.Un control diabetes mellitus
2.History of IHD
3.History of drug/alcohol abuse
4.Non cooperative patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of Serum Cholesterol and Serum TriglyceridesTimepoint: Baseline, 1st month, 2nd month, 3rd month
- Secondary Outcome Measures
Name Time Method Safety with Pathological and biochemical testsTimepoint: Before and after treatment